The Food and Drug Administration (FDA) is reviewing an ER formulation of alfuzosin hydrochloride 10 mg for once-daily administration for treatment of symptomatic BPH. The IR and twice-daily ER ...

Alfuzosin is available as a generic drug and as a brand-name drug. Brand name: Uroxatral. Alfuzosin only comes as an extended-release oral tablet. Alfuzosin is used to treat benign prostatic ...

This randomized, double-blind, placebo-controlled study was conducted at 52 sites in the United States from 10 January 2003 to 18 August 2003. An amendment to the original study protocol, made on 22 ...

Alfuzosin (Xelflo) is used to treat an enlarged prostate or benign prostatic hyperplasia (BPH) symptoms in men by relaxing the muscles in the prostate and bladder neck and helps to urinate easily. It ...

Wockhardt announced that it has received final approval from the FDA for Alfuzosin HCl Extended-Release Tablets, the generic version of Sanofi-Aventis‘ Uroxatral. Alfuzosin HCl is an α 1-blocker ...

PARSIPPANY, N.J. and MUMBAI, India, Aug. 14, 2012 /PRNewswire/ -- Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA ...

Sun Pharmaceutical Industries today said it has received the US health regulator's nod to market Alfuzosin Hydrochloride tablets, used in the treatment of prostatic hyperplasia, in the American market ...

PITTSBURGH, Aug. 12, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has shipped Alfuzosin Hydrochloride Extended-release Tablets, 10 mg.

PITTSBURGH, Oct. 22 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL - News) today announced that its subsidiary, Mylan Pharmaceuticals Inc., received tentative ...

When compared with prazosin, IR alfuzosin had comparable efficacy and caused less cardiovascular adverse effects. Buzelin et al. [55] compared the effects of alfuzosin with prazosin in 103 patients.

Sun Pharmaceutical Industries on Tuesday said it has received the US health regulator's nod to market Alfuzosin Hydrochloride tablets, used in the treatment of prostatic hyperplasia, in the American ...